Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy [Original Articles]

Conclusions:
HCM was identified in 30% of relatives at first screening, and 16% developed HCM during 7 years of repeated evaluation. GT led to a discharge from clinical follow-up in 46% of the study population. Survival in the relatives was good.

Source: Circulation: Cardiovascular Genetics - April 16, 2018 Category: Cardiology Authors: van Velzen, H. G., Schinkel, A. F. L., Baart, S. J., Oldenburg, R. A., Frohn-Mulder, I. M. E., van Slegtenhorst, M. A., Michels, M. Tags: Clinical Studies, Genetics, Cardiomyopathy, Hypertrophy, Mortality/Survival Original Articles Source Type: research